Viewing Study NCT04876456


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-30 @ 1:00 PM
Study NCT ID: NCT04876456
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2021-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Sponsor: Jennifer King
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module